≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Assault by other and unspecified firearm discharge

Endpoint Browser

VWXY20_ASSAU_OTHER_UNSPE_FIREA_DISCH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — X95
  • Cause of death: ICD-10 — X95

2 out of 7 registries used, show all original rules.

61

4. Check minimum number of events

None

61

5. Include endpoints

None

61

6. Filter based on genotype QC (FinnGen only)

61

Control definitions (FinnGen only)

Control exclude
VWXY20_ASSAULT

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
X85-Y09

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 61 16 45
Unadjusted period prevalence (%) 0.02 0.01 0.02
Median age at first event (years) 41.59 40.82 41.86

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
51
Matched controls
510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
X95.9
ICD-10 Finland
Assault by other and unspecified firearm discharge by unknown person
+∞
25.1
22
*
X95.0
ICD-10 Finland
Assault by other and unspecified firearm discharge by spouse or partner
+∞
21.3
19
*
X95.8
ICD-10 Finland
Assault by other and unspecified firearm discharge by other known person
+∞
11.9
11
*
ZXD05
NOMESCO Finland
Urgent procedure
6.3
8.6
29
88
N05AH04
ATC
quetiapine; oral
6.5
7.1
20
46
JAH00
NOMESCO Finland
Laparotomy
46.4
7.0
8
*
ZXA00
NOMESCO Finland
Right side
6.3
6.7
19
44
N05BA01
ATC
diazepam; systemic, rectal
7.3
6.5
16
30
X58
ICD-10 Finland
Exposure to other specified factors
6.7
6.5
17
35
T36
ICD-10 Finland
Poisoning by systemic antibiotics
12.4
6.4
11
11
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
+∞
6.4
6
*
N05BA04
ATC
oxazepam; oral
5.1
6.2
22
66

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
11
10
13.20
10.46
3.9
2.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
14
10.43
9.69
6.0
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
38
174
4.14
6.85
8.6
5.2
g/l
34.4
37.5
1.78
38
165
(3023368) Bacteria identified in Blood by Culture
30
117
4.08
6.79
9.6
4.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
18
7.24
6.68
3.9
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
30
121
3.91
6.40
2.0
1.9
pmol/l
98.6
93.3
0.23
16
65
(3042936) Bacteria identified in Isolate by Culture
18
53
4.40
5.85
3.9
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
25
5.73
5.77
3.8
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
26
5.50
5.53
3.8
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
26
5.50
5.53
3.8
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
26
5.50
5.53
2.3
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
26
5.50
5.53
3.8
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
18
57
4.06
5.28
2.7
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
27
134
2.82
3.72
2.7
2.1
u/l
333.1
237.1
0.19
27
129
(3013115) Eosinophils [#/volume] in Blood
38
227
2.79
3.64
8.6
8.8
e9/l
0.2
0.2
0.23
31
200
(42870588) Differential panel, method unspecified - Blood
28
144
2.75
3.58
7.4
7.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
37
224
2.66
3.36
7.9
8.0
e9/l
0.0
0.0
0.04
31
195
(3001604) Monocytes [#/volume] in Blood
37
224
2.66
3.36
7.9
8.0
e9/l
0.6
0.6
0.02
31
194
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
20
90
2.82
3.24
4.9
2.8
ng/l
14.1
30.8
0.65
13
62
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
29
3.93
3.20
2.0
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
19
84
2.83
3.18
4.0
2.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
37
229
2.56
3.14
8.0
8.2
e9/l
2.0
1.8
0.82
32
201
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
106
2.68
3.13
1.8
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
5
10.72
3.03
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
139
2.52
2.98
2.7
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
18
82
2.70
2.82
2.9
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
10
6.51
2.76
1.7
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
83
2.66
2.75
3.2
2.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
7
7.64
2.59
1.2
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
39
262
2.35
2.58
12.7
11.9
e9/l
4.4
4.3
0.03
34
229
(3012516) Albumin [Mass/volume] in Urine
20
102
2.43
2.47
3.6
3.5
mg/l
3687.4
57.3
0.48
12
63
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
17
4.50
2.44
9.6
7.3
—
—
—
0
0
(3012544) pH of Venous blood
11
42
2.98
2.33
4.6
4.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
13
4.99
2.33
2.5
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
20
106
2.32
2.25
5.0
4.3
mg/mmol
18.7
10.0
0.28
13
71
(3044889) 12 lead EKG panel
44
324
2.28
2.17
3.1
3.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
13
57
2.63
2.15
4.0
2.7
umol/l
12.0
14.7
0.59
13
52
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
86
2.35
2.11
1.6
1.8
—
—
—
0
0
(3015736) pH of Urine
29
184
2.10
2.08
3.3
3.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
7
21
3.62
2.03
7.9
1.9
ng/l
117.4
113.7
—
7
16
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
27
168
2.09
2.02
4.0
3.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
6
16
4.04
1.99
2.2
1.6
mg/l
421.7
527.8
—
6
16
(3002582) Erythrocytes [#/volume] in Urine
24
148
2.02
1.81
4.5
2.8
e6/l
25.5
23.7
0.03
18
111
(3018095) Leukocytes [#/volume] in Urine
26
166
1.99
1.77
5.3
3.4
e6/l
25.7
21.2
0.14
19
116
(3019225) pH of Specimen
8
31
2.81
1.73
4.1
2.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
25
3.03
1.70
1.1
4.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
26
168
1.95
1.70
10.8
7.5
inr
1.2
1.2
—
7
48
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
94
2.12
1.69
3.7
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
57
2.38
1.68
3.7
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
51
418
2.34
1.67
29.4
14.3
%
13.8
13.5
0.86
51
413
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
20
3.21
1.62
2.3
2.8
kpa
5.3
5.1
—
6
20
(3037467) Urinalysis macro (dipstick) panel - Urine
41
313
1.95
1.60
5.2
3.8
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
15
3.53
1.55
2.0
1.4
mmol/l
3.5
3.7
—
5
15
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
15
3.53
1.55
1.6
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
49
401
2.13
1.52
4.3
3.2
—
—
—
0
0
(3013512) EKG study
17
98
2.02
1.51
4.1
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
39
2.53
1.51
3.3
2.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
28
2.69
1.50
3.0
4.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
53
2.31
1.49
1.1
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
16
3.31
1.47
1.0
3.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
12
61
2.20
1.44
3.5
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
56
495
2.60
1.44
30.2
11.7
mg/l
21.5
22.5
0.10
51
384
(3021589) Normoblasts [#/volume] in Blood
29
203
1.82
1.44
13.4
9.8
e9/l
0.0
0.0
0.50
24
167
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
77
2.06
1.39
3.6
2.4
e6/l
6.4
1.7
—
7
37
(3030981) Hyaline casts [#/volume] in Urine by Automated count
5
17
3.11
1.38
2.0
1.9
e6/l
0.5
0.0
—
5
17
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
35
2.48
1.33
3.3
2.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
18
2.93
1.31
1.2
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
36
2.40
1.30
10.8
7.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
25
2.55
1.27
1.3
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
21
138
1.80
1.25
4.7
2.9
e6/l
0.0
0.3
1.60
14
100
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
27
192
1.73
1.23
6.0
3.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
26
2.45
1.22
2.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
24
167
1.72
1.17
4.4
2.7
ng/l
12.5
22.3
1.64
14
101
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
17
108
1.80
1.12
1.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
47
2.07
1.08
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
21
144
1.70
1.06
1.8
2.5
umol/l
352.2
3538.0
0.50
21
129
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
22
2.38
1.05
1.8
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
22
2.38
1.05
10.0
5.7
mmol/l
24.8
25.8
—
5
22
(3001019) Free T4 and TSH panel - Serum or Plasma
0
31
0.00
0.99
0.0
2.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
7
37
2.00
0.97
1.7
2.5
%
2.5
1.7
—
7
31
(40758558) Short blood count panel - Blood
17
113
1.70
0.95
15.8
7.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
20
140
1.64
0.93
4.7
2.8
—
—
—
0
0
(3002256) Pathology report gross observation
8
48
1.77
0.82
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
17
118
1.61
0.80
1.5
1.7
mmol/l
1.5
1.6
0.16
17
101
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
24
2.18
0.76
2.8
3.2
%
1.1
2.0
—
5
24
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
39
1.90
0.75
4.0
2.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
25
2.09
0.74
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
13
86
1.65
0.73
3.6
2.4
e6/l
0.8
0.8
—
6
47
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
41
1.80
0.73
1.4
2.2
nmol/l
34.1
35.3
—
7
41
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
21
157
1.51
0.72
3.1
2.7
nmol/l
71.7
76.3
0.21
21
145
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
28
1.85
0.68
2.8
4.3
g/l
134.6
131.8
—
5
28
(3025941) Bacteria identified in Stool by Culture
5
29
1.79
0.65
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
19
237
0.71
0.53
2.6
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
9
129
0.65
0.50
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
49
449
1.46
0.49
5.7
4.3
mmol/mol
38.4
38.4
0.00
49
425
(4010399)
5
32
1.61
0.43
1.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
71
1.49
0.42
2.5
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
50
464
1.43
0.42
20.8
10.2
ml/min/173m2
97.5
89.9
1.63
44
395
(4034850)
0
15
0.00
0.42
0.0
22.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
15
0.00
0.42
0.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
44
1.40
0.35
1.3
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12
95
1.33
0.29
5.3
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
73
0.66
0.28
1.2
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
15
124
1.28
0.27
3.5
5.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5
41
1.24
0.22
4.2
3.8
%
31.8
30.2
—
5
25
(4268621)
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(4306422)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
1.6
—
157.2
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
12
0.00
0.21
0.0
1.1
—
8.9
—
0
7
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
27
245
1.18
0.20
4.6
3.3
estimate
0.0
0.0
—
5
45
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
1.0
—
0
7
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
52
1.17
0.20
19.8
11.8
—
—
—
0
0
(3000492) Spirometry study
7
61
1.17
0.18
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
18
161
1.17
0.15
2.1
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
21
192
1.14
0.13
4.4
3.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
15
134
1.16
0.12
7.1
2.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
16
144
1.15
0.12
4.5
2.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
6
53
1.15
0.09
1.0
2.6
nmol/l
306.5
403.4
—
6
48
(40768797) Stomach Pathology biopsy report
5
61
0.80
0.08
1.4
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
26
246
1.10
0.08
6.5
4.3
estimate
0.0
0.0
—
5
45
(3029937) Albumin [Presence] in Urine by Test strip
12
130
0.90
0.05
5.7
3.9
estimate
0.0
0.0
—
5
43
(3009261) Glucose [Presence] in Urine by Test strip
26
250
1.07
0.04
4.7
3.3
estimate
0.0
0.0
—
5
42
(3009542) Hematocrit [Volume Fraction] of Blood
49
499
0.91
0.04
29.5
12.0
%
41.9
42.7
0.52
33
422
(3011397) Hemoglobin [Presence] in Urine by Test strip
12
114
1.07
0.01
4.0
4.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
8
0.00
0.00
0.0
1.5
—
88.5
—
0
8
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
194.9
—
0
6
(3045424) Erythrocytes [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
573.0
—
0
6
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
2.0
—
13.2
—
0
6
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
251.7
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
7.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
7
0.00
0.00
0.0
5.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
55
0.90
0.00
1.6
1.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
3.3
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.4
—
12.8
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_ASSAU_OTHER_UNSPE_FIREA_DISCH – Assault by other and unspecified firearm discharge

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).